Literature DB >> 1572734

High-risk coronary angioplasty with elective intra-aortic balloon pump support.

I Kreidieh1, D W Davies, R Lim, A W Nathan, D S Dymond, S O Banim.   

Abstract

Percutaneous transluminal coronary angioplasty was attempted with elective percutaneous intra-aortic balloon pump support in 21 patients (mean age 60 years, range 40-82; 18 males) with unstable angina (n = 2), multivessel coronary disease requiring multivessel angioplasty (n = 2), severe left ventricular dysfunction (ejection fraction 10-30%; n = 16) or ventricular fibrillation at diagnostic angiography (n = 1). Fourteen patients had 3-vessel disease (1 with vein grafts also diseased), 6 had 2-vessel disease and 1 had isolated left anterior descending disease. Twenty-five procedures were performed (one in 18 patients, two in 2 patients and three in one patient) on 42 lesions in 34 vessels/grafts. There was no angioplasty-related death. Successful dilatation was achieved in 38/42 lesions (90%) in 21/25 procedures (84%) without major complication. Three procedures were complicated: one by major coronary dissection without sequelae, one by haemodynamic deterioration due to distal occlusion and one by an unstable residual stenosis in the attempted vessel necessitating urgent bypass surgery. The only complication related to the intra-aortic balloon pump was local haematoma in 2 patients. In conclusion, elective intra-aortic balloon pump support may be safely used to stabilise high-risk patients undergoing coronary angioplasty, leading to a satisfactory primary success rate.

Entities:  

Mesh:

Year:  1992        PMID: 1572734     DOI: 10.1016/0167-5273(92)90171-x

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.

Authors:  Jeptha P Curtis; Saif S Rathore; Yongfei Wang; Jersey Chen; Brahmajee K Nallamothu; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.